nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP3A7—Ifosfamide—germ cell cancer	0.121	0.191	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.121	0.191	CbGbCtD
Nefazodone—CYP3A5—Ifosfamide—germ cell cancer	0.091	0.143	CbGbCtD
Nefazodone—ABCB1—Dactinomycin—germ cell cancer	0.0502	0.0789	CbGbCtD
Nefazodone—CYP3A5—Etoposide—germ cell cancer	0.0435	0.0684	CbGbCtD
Nefazodone—CYP3A4—Ifosfamide—germ cell cancer	0.0355	0.0558	CbGbCtD
Nefazodone—ABCB1—Vinblastine—germ cell cancer	0.0314	0.0494	CbGbCtD
Nefazodone—CYP2D6—Vinblastine—germ cell cancer	0.0296	0.0466	CbGbCtD
Nefazodone—ABCB1—Cisplatin—germ cell cancer	0.0288	0.0453	CbGbCtD
Nefazodone—ABCB1—Etoposide—germ cell cancer	0.0283	0.0445	CbGbCtD
Nefazodone—CYP3A4—Vinblastine—germ cell cancer	0.0188	0.0296	CbGbCtD
Nefazodone—ABCB1—Methotrexate—germ cell cancer	0.0187	0.0294	CbGbCtD
Nefazodone—CYP3A4—Etoposide—germ cell cancer	0.017	0.0267	CbGbCtD
Nefazodone—HTR2C—choroid plexus—germ cell cancer	0.0151	0.0971	CbGeAlD
Nefazodone—HTR2A—phrenic nerve—germ cell cancer	0.0105	0.0673	CbGeAlD
Nefazodone—HTR2A—choroid plexus—germ cell cancer	0.0076	0.0487	CbGeAlD
Nefazodone—HTR2A—myenteric nerve plexus—germ cell cancer	0.00539	0.0345	CbGeAlD
Nefazodone—SLC6A3—telencephalic ventricle—germ cell cancer	0.00459	0.0294	CbGeAlD
Nefazodone—HTR2C—telencephalic ventricle—germ cell cancer	0.00444	0.0284	CbGeAlD
Nefazodone—HTR2A—trigeminal nerve—germ cell cancer	0.00384	0.0246	CbGeAlD
Nefazodone—HTR1A—telencephalic ventricle—germ cell cancer	0.00373	0.0239	CbGeAlD
Nefazodone—HTR2A—vagus nerve—germ cell cancer	0.00359	0.023	CbGeAlD
Nefazodone—SLC6A3—ganglion—germ cell cancer	0.00286	0.0183	CbGeAlD
Nefazodone—HTR2C—ganglion—germ cell cancer	0.00276	0.0177	CbGeAlD
Nefazodone—HTR2A—cranial nerve—germ cell cancer	0.00274	0.0175	CbGeAlD
Nefazodone—HTR2A—pons—germ cell cancer	0.0027	0.0173	CbGeAlD
Nefazodone—SLC6A4—ganglion—germ cell cancer	0.00262	0.0168	CbGeAlD
Nefazodone—HTR1A—ganglion—germ cell cancer	0.00232	0.0149	CbGeAlD
Nefazodone—SLC6A2—ganglion—germ cell cancer	0.0023	0.0148	CbGeAlD
Nefazodone—HTR2A—telencephalic ventricle—germ cell cancer	0.00223	0.0143	CbGeAlD
Nefazodone—HTR2A—urine—germ cell cancer	0.00203	0.013	CbGeAlD
Nefazodone—HTR2A—appendage—germ cell cancer	0.00198	0.0127	CbGeAlD
Nefazodone—HTR2A—pineal body—germ cell cancer	0.00193	0.0124	CbGeAlD
Nefazodone—CYP3A4—urine—germ cell cancer	0.00188	0.0121	CbGeAlD
Nefazodone—CYP2D6—urine—germ cell cancer	0.00185	0.0119	CbGeAlD
Nefazodone—HTR2A—ganglion—germ cell cancer	0.00139	0.00888	CbGeAlD
Nefazodone—SLC6A3—brainstem—germ cell cancer	0.00124	0.00796	CbGeAlD
Nefazodone—HTR2C—brainstem—germ cell cancer	0.0012	0.00769	CbGeAlD
Nefazodone—HTR2A—endothelium—germ cell cancer	0.00119	0.00766	CbGeAlD
Nefazodone—CYP3A7—endocrine gland—germ cell cancer	0.00118	0.00757	CbGeAlD
Nefazodone—SLC6A4—brainstem—germ cell cancer	0.00114	0.00729	CbGeAlD
Nefazodone—SLC6A3—telencephalon—germ cell cancer	0.0011	0.00706	CbGeAlD
Nefazodone—HTR2A—blood vessel—germ cell cancer	0.0011	0.00706	CbGeAlD
Nefazodone—HTR2C—telencephalon—germ cell cancer	0.00107	0.00683	CbGeAlD
Nefazodone—HTR1A—brainstem—germ cell cancer	0.00101	0.00648	CbGeAlD
Nefazodone—SLC6A4—telencephalon—germ cell cancer	0.00101	0.00647	CbGeAlD
Nefazodone—SLC6A2—brainstem—germ cell cancer	0.001	0.00642	CbGeAlD
Nefazodone—ADRA1A—brainstem—germ cell cancer	0.000931	0.00597	CbGeAlD
Nefazodone—ADRA1B—head—germ cell cancer	0.000916	0.00587	CbGeAlD
Nefazodone—HTR1A—telencephalon—germ cell cancer	0.000897	0.00575	CbGeAlD
Nefazodone—SLC6A2—telencephalon—germ cell cancer	0.000889	0.0057	CbGeAlD
Nefazodone—SLC6A2—decidua—germ cell cancer	0.000843	0.0054	CbGeAlD
Nefazodone—HTR2C—medulla oblongata—germ cell cancer	0.000837	0.00536	CbGeAlD
Nefazodone—ADRA1A—telencephalon—germ cell cancer	0.000827	0.0053	CbGeAlD
Nefazodone—ADRA2A—trigeminal ganglion—germ cell cancer	0.0008	0.00513	CbGeAlD
Nefazodone—SLC6A3—midbrain—germ cell cancer	0.000791	0.00507	CbGeAlD
Nefazodone—HTR2A—neck—germ cell cancer	0.000788	0.00505	CbGeAlD
Nefazodone—SLC6A3—spinal cord—germ cell cancer	0.000772	0.00495	CbGeAlD
Nefazodone—HTR2C—midbrain—germ cell cancer	0.000765	0.0049	CbGeAlD
Nefazodone—HTR2C—spinal cord—germ cell cancer	0.000746	0.00478	CbGeAlD
Nefazodone—SLC6A2—gonad—germ cell cancer	0.000742	0.00476	CbGeAlD
Nefazodone—SLC6A4—midbrain—germ cell cancer	0.000725	0.00465	CbGeAlD
Nefazodone—ABCB1—blood vessel—germ cell cancer	0.000722	0.00463	CbGeAlD
Nefazodone—SLC6A4—spinal cord—germ cell cancer	0.000708	0.00453	CbGeAlD
Nefazodone—SLC6A2—medulla oblongata—germ cell cancer	0.000699	0.00448	CbGeAlD
Nefazodone—SLC6A3—head—germ cell cancer	0.000686	0.0044	CbGeAlD
Nefazodone—ADRA1B—brain—germ cell cancer	0.000664	0.00425	CbGeAlD
Nefazodone—HTR2C—head—germ cell cancer	0.000663	0.00425	CbGeAlD
Nefazodone—SLC6A3—testis—germ cell cancer	0.000663	0.00425	CbGeAlD
Nefazodone—HTR2A—embryo—germ cell cancer	0.000657	0.00421	CbGeAlD
Nefazodone—HTR1A—adrenal gland—germ cell cancer	0.000652	0.00418	CbGeAlD
Nefazodone—SLC6A2—adrenal gland—germ cell cancer	0.000647	0.00414	CbGeAlD
Nefazodone—HTR1A—midbrain—germ cell cancer	0.000644	0.00413	CbGeAlD
Nefazodone—SLC6A4—endocrine gland—germ cell cancer	0.000637	0.00408	CbGeAlD
Nefazodone—SLC6A4—head—germ cell cancer	0.000629	0.00403	CbGeAlD
Nefazodone—ADRA2A—telencephalon—germ cell cancer	0.000629	0.00403	CbGeAlD
Nefazodone—HTR1A—spinal cord—germ cell cancer	0.000628	0.00403	CbGeAlD
Nefazodone—SLC6A3—cerebellum—germ cell cancer	0.000612	0.00392	CbGeAlD
Nefazodone—HTR2A—brainstem—germ cell cancer	0.000602	0.00386	CbGeAlD
Nefazodone—ADRA1A—adrenal gland—germ cell cancer	0.000601	0.00385	CbGeAlD
Nefazodone—ADRA2A—decidua—germ cell cancer	0.000596	0.00382	CbGeAlD
Nefazodone—HTR2A—eye—germ cell cancer	0.000586	0.00376	CbGeAlD
Nefazodone—HTR2A—retina—germ cell cancer	0.000581	0.00372	CbGeAlD
Nefazodone—HTR1A—endocrine gland—germ cell cancer	0.000566	0.00362	CbGeAlD
Nefazodone—SLC6A2—endocrine gland—germ cell cancer	0.000561	0.00359	CbGeAlD
Nefazodone—HTR1A—head—germ cell cancer	0.000558	0.00358	CbGeAlD
Nefazodone—SLC6A2—head—germ cell cancer	0.000554	0.00355	CbGeAlD
Nefazodone—CYP2D6—brainstem—germ cell cancer	0.000549	0.00352	CbGeAlD
Nefazodone—SLC6A2—testis—germ cell cancer	0.000535	0.00343	CbGeAlD
Nefazodone—HTR2A—telencephalon—germ cell cancer	0.000534	0.00342	CbGeAlD
Nefazodone—ADRA2A—gonad—germ cell cancer	0.000525	0.00336	CbGeAlD
Nefazodone—ADRA1A—endocrine gland—germ cell cancer	0.000521	0.00334	CbGeAlD
Nefazodone—ADRA2A—uterus—germ cell cancer	0.000521	0.00334	CbGeAlD
Nefazodone—ADRA1A—head—germ cell cancer	0.000515	0.0033	CbGeAlD
Nefazodone—ADRA2A—pituitary gland—germ cell cancer	0.000512	0.00328	CbGeAlD
Nefazodone—HTR1A—cerebellum—germ cell cancer	0.000498	0.00319	CbGeAlD
Nefazodone—SLC6A3—brain—germ cell cancer	0.000497	0.00319	CbGeAlD
Nefazodone—ADRA2A—medulla oblongata—germ cell cancer	0.000494	0.00316	CbGeAlD
Nefazodone—Vision blurred—Ifosfamide—germ cell cancer	0.00049	0.00235	CcSEcCtD
Nefazodone—CYP2D6—telencephalon—germ cell cancer	0.000487	0.00312	CbGeAlD
Nefazodone—Thrombocytopenia—Bleomycin—germ cell cancer	0.000486	0.00233	CcSEcCtD
Nefazodone—Feeling abnormal—Vinblastine—germ cell cancer	0.000484	0.00232	CcSEcCtD
Nefazodone—Myalgia—Dactinomycin—germ cell cancer	0.000483	0.00232	CcSEcCtD
Nefazodone—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000482	0.00231	CcSEcCtD
Nefazodone—HTR2C—brain—germ cell cancer	0.000481	0.00308	CbGeAlD
Nefazodone—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00048	0.00231	CcSEcCtD
Nefazodone—Anaemia—Ifosfamide—germ cell cancer	0.00048	0.0023	CcSEcCtD
Nefazodone—Tinnitus—Cisplatin—germ cell cancer	0.00048	0.0023	CcSEcCtD
Nefazodone—Lymphadenopathy—Methotrexate—germ cell cancer	0.000478	0.0023	CcSEcCtD
Nefazodone—Flushing—Cisplatin—germ cell cancer	0.000477	0.00229	CcSEcCtD
Nefazodone—Agitation—Ifosfamide—germ cell cancer	0.000477	0.00229	CcSEcCtD
Nefazodone—Discomfort—Dactinomycin—germ cell cancer	0.000477	0.00229	CcSEcCtD
Nefazodone—Angioedema—Ifosfamide—germ cell cancer	0.000475	0.00228	CcSEcCtD
Nefazodone—Anorexia—Bleomycin—germ cell cancer	0.000473	0.00227	CcSEcCtD
Nefazodone—Hypoaesthesia—Etoposide—germ cell cancer	0.000469	0.00225	CcSEcCtD
Nefazodone—Malaise—Ifosfamide—germ cell cancer	0.000468	0.00225	CcSEcCtD
Nefazodone—Vertigo—Ifosfamide—germ cell cancer	0.000467	0.00224	CcSEcCtD
Nefazodone—Leukopenia—Ifosfamide—germ cell cancer	0.000465	0.00223	CcSEcCtD
Nefazodone—Polyuria—Methotrexate—germ cell cancer	0.000465	0.00223	CcSEcCtD
Nefazodone—Abdominal pain—Vinblastine—germ cell cancer	0.000464	0.00223	CcSEcCtD
Nefazodone—Hypotension—Bleomycin—germ cell cancer	0.000464	0.00223	CcSEcCtD
Nefazodone—Oedema—Dactinomycin—germ cell cancer	0.000463	0.00222	CcSEcCtD
Nefazodone—Infection—Dactinomycin—germ cell cancer	0.00046	0.00221	CcSEcCtD
Nefazodone—ADRA1A—cerebellum—germ cell cancer	0.000459	0.00294	CbGeAlD
Nefazodone—Palpitations—Ifosfamide—germ cell cancer	0.000459	0.0022	CcSEcCtD
Nefazodone—ADRA2A—adrenal gland—germ cell cancer	0.000457	0.00293	CbGeAlD
Nefazodone—SLC6A4—brain—germ cell cancer	0.000456	0.00292	CbGeAlD
Nefazodone—Alopecia—Cisplatin—germ cell cancer	0.000455	0.00218	CcSEcCtD
Nefazodone—Hepatic failure—Methotrexate—germ cell cancer	0.000454	0.00218	CcSEcCtD
Nefazodone—Cough—Ifosfamide—germ cell cancer	0.000453	0.00218	CcSEcCtD
Nefazodone—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000453	0.00217	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000452	0.00217	CcSEcCtD
Nefazodone—ADRA2A—midbrain—germ cell cancer	0.000451	0.00289	CbGeAlD
Nefazodone—Convulsion—Ifosfamide—germ cell cancer	0.00045	0.00216	CcSEcCtD
Nefazodone—Hypertension—Ifosfamide—germ cell cancer	0.000449	0.00215	CcSEcCtD
Nefazodone—CYP3A5—female gonad—germ cell cancer	0.000447	0.00287	CbGeAlD
Nefazodone—HTR2A—gonad—germ cell cancer	0.000446	0.00286	CbGeAlD
Nefazodone—ABCB1—trigeminal ganglion—germ cell cancer	0.000446	0.00286	CbGeAlD
Nefazodone—Erythema multiforme—Etoposide—germ cell cancer	0.000446	0.00214	CcSEcCtD
Nefazodone—Paraesthesia—Bleomycin—germ cell cancer	0.000445	0.00214	CcSEcCtD
Nefazodone—Dyspnoea—Bleomycin—germ cell cancer	0.000442	0.00212	CcSEcCtD
Nefazodone—Arthralgia—Ifosfamide—germ cell cancer	0.000442	0.00212	CcSEcCtD
Nefazodone—Chest pain—Ifosfamide—germ cell cancer	0.000442	0.00212	CcSEcCtD
Nefazodone—Myalgia—Ifosfamide—germ cell cancer	0.000442	0.00212	CcSEcCtD
Nefazodone—Flatulence—Cisplatin—germ cell cancer	0.000441	0.00212	CcSEcCtD
Nefazodone—Anorexia—Dactinomycin—germ cell cancer	0.000441	0.00212	CcSEcCtD
Nefazodone—ADRA2A—spinal cord—germ cell cancer	0.00044	0.00282	CbGeAlD
Nefazodone—Flushing—Etoposide—germ cell cancer	0.000437	0.0021	CcSEcCtD
Nefazodone—Discomfort—Ifosfamide—germ cell cancer	0.000437	0.0021	CcSEcCtD
Nefazodone—HTR2A—pituitary gland—germ cell cancer	0.000435	0.00279	CbGeAlD
Nefazodone—Hypersensitivity—Vinblastine—germ cell cancer	0.000433	0.00208	CcSEcCtD
Nefazodone—Decreased appetite—Bleomycin—germ cell cancer	0.000431	0.00207	CcSEcCtD
Nefazodone—Visual disturbance—Methotrexate—germ cell cancer	0.000431	0.00207	CcSEcCtD
Nefazodone—ABCB1—embryo—germ cell cancer	0.000431	0.00276	CbGeAlD
Nefazodone—Muscle spasms—Cisplatin—germ cell cancer	0.000431	0.00207	CcSEcCtD
Nefazodone—Confusional state—Ifosfamide—germ cell cancer	0.000428	0.00205	CcSEcCtD
Nefazodone—ADRA2A—female gonad—germ cell cancer	0.000426	0.00273	CbGeAlD
Nefazodone—Pain—Bleomycin—germ cell cancer	0.000424	0.00204	CcSEcCtD
Nefazodone—Oedema—Ifosfamide—germ cell cancer	0.000424	0.00204	CcSEcCtD
Nefazodone—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000424	0.00204	CcSEcCtD
Nefazodone—Chills—Etoposide—germ cell cancer	0.000423	0.00203	CcSEcCtD
Nefazodone—Vision blurred—Cisplatin—germ cell cancer	0.000422	0.00203	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000422	0.00202	CcSEcCtD
Nefazodone—Asthenia—Vinblastine—germ cell cancer	0.000421	0.00202	CcSEcCtD
Nefazodone—Infection—Ifosfamide—germ cell cancer	0.000421	0.00202	CcSEcCtD
Nefazodone—HTR2A—medulla oblongata—germ cell cancer	0.00042	0.00269	CbGeAlD
Nefazodone—Tremor—Cisplatin—germ cell cancer	0.00042	0.00201	CcSEcCtD
Nefazodone—Alopecia—Etoposide—germ cell cancer	0.000417	0.002	CcSEcCtD
Nefazodone—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000416	0.002	CcSEcCtD
Nefazodone—CYP3A5—endocrine gland—germ cell cancer	0.000416	0.00266	CbGeAlD
Nefazodone—Ill-defined disorder—Cisplatin—germ cell cancer	0.000416	0.00199	CcSEcCtD
Nefazodone—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000415	0.00199	CcSEcCtD
Nefazodone—Anaemia—Cisplatin—germ cell cancer	0.000414	0.00199	CcSEcCtD
Nefazodone—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00041	0.00197	CcSEcCtD
Nefazodone—Feeling abnormal—Bleomycin—germ cell cancer	0.000409	0.00196	CcSEcCtD
Nefazodone—Osteoarthritis—Methotrexate—germ cell cancer	0.000408	0.00196	CcSEcCtD
Nefazodone—HTR1A—brain—germ cell cancer	0.000405	0.00259	CbGeAlD
Nefazodone—Anorexia—Ifosfamide—germ cell cancer	0.000404	0.00194	CcSEcCtD
Nefazodone—Malaise—Cisplatin—germ cell cancer	0.000404	0.00194	CcSEcCtD
Nefazodone—Decreased appetite—Dactinomycin—germ cell cancer	0.000402	0.00193	CcSEcCtD
Nefazodone—Diarrhoea—Vinblastine—germ cell cancer	0.000402	0.00193	CcSEcCtD
Nefazodone—Dysgeusia—Etoposide—germ cell cancer	0.000402	0.00193	CcSEcCtD
Nefazodone—SLC6A2—brain—germ cell cancer	0.000401	0.00257	CbGeAlD
Nefazodone—Leukopenia—Cisplatin—germ cell cancer	0.000401	0.00192	CcSEcCtD
Nefazodone—Back pain—Etoposide—germ cell cancer	0.000397	0.00191	CcSEcCtD
Nefazodone—ADRA2A—endocrine gland—germ cell cancer	0.000396	0.00254	CbGeAlD
Nefazodone—Hypotension—Ifosfamide—germ cell cancer	0.000396	0.0019	CcSEcCtD
Nefazodone—Pain—Dactinomycin—germ cell cancer	0.000396	0.0019	CcSEcCtD
Nefazodone—Muscle spasms—Etoposide—germ cell cancer	0.000394	0.00189	CcSEcCtD
Nefazodone—Urticaria—Bleomycin—germ cell cancer	0.000394	0.00189	CcSEcCtD
Nefazodone—Body temperature increased—Bleomycin—germ cell cancer	0.000392	0.00188	CcSEcCtD
Nefazodone—ADRA2A—head—germ cell cancer	0.000391	0.00251	CbGeAlD
Nefazodone—HTR2A—adrenal gland—germ cell cancer	0.000389	0.00249	CbGeAlD
Nefazodone—Dizziness—Vinblastine—germ cell cancer	0.000388	0.00186	CcSEcCtD
Nefazodone—Convulsion—Cisplatin—germ cell cancer	0.000388	0.00186	CcSEcCtD
Nefazodone—SLC6A2—lymph node—germ cell cancer	0.000388	0.00248	CbGeAlD
Nefazodone—Mood swings—Methotrexate—germ cell cancer	0.000387	0.00186	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000386	0.00185	CcSEcCtD
Nefazodone—HTR2A—midbrain—germ cell cancer	0.000384	0.00246	CbGeAlD
Nefazodone—Ataxia—Methotrexate—germ cell cancer	0.000384	0.00184	CcSEcCtD
Nefazodone—Myalgia—Cisplatin—germ cell cancer	0.000381	0.00183	CcSEcCtD
Nefazodone—Feeling abnormal—Dactinomycin—germ cell cancer	0.000381	0.00183	CcSEcCtD
Nefazodone—Paraesthesia—Ifosfamide—germ cell cancer	0.000381	0.00183	CcSEcCtD
Nefazodone—ABCB1—retina—germ cell cancer	0.000381	0.00244	CbGeAlD
Nefazodone—Ill-defined disorder—Etoposide—germ cell cancer	0.000381	0.00183	CcSEcCtD
Nefazodone—Anxiety—Cisplatin—germ cell cancer	0.00038	0.00182	CcSEcCtD
Nefazodone—Anaemia—Etoposide—germ cell cancer	0.000379	0.00182	CcSEcCtD
Nefazodone—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000378	0.00182	CcSEcCtD
Nefazodone—ADRA2A—testis—germ cell cancer	0.000378	0.00242	CbGeAlD
Nefazodone—Dyspnoea—Ifosfamide—germ cell cancer	0.000378	0.00181	CcSEcCtD
Nefazodone—Somnolence—Ifosfamide—germ cell cancer	0.000377	0.00181	CcSEcCtD
Nefazodone—Liver function test abnormal—Methotrexate—germ cell cancer	0.000377	0.00181	CcSEcCtD
Nefazodone—Discomfort—Cisplatin—germ cell cancer	0.000377	0.00181	CcSEcCtD
Nefazodone—HTR2A—spinal cord—germ cell cancer	0.000374	0.0024	CbGeAlD
Nefazodone—Vomiting—Vinblastine—germ cell cancer	0.000373	0.00179	CcSEcCtD
Nefazodone—ADRA1A—brain—germ cell cancer	0.000373	0.00239	CbGeAlD
Nefazodone—Malaise—Etoposide—germ cell cancer	0.00037	0.00178	CcSEcCtD
Nefazodone—Vertigo—Etoposide—germ cell cancer	0.000369	0.00177	CcSEcCtD
Nefazodone—Decreased appetite—Ifosfamide—germ cell cancer	0.000369	0.00177	CcSEcCtD
Nefazodone—Headache—Vinblastine—germ cell cancer	0.000368	0.00177	CcSEcCtD
Nefazodone—Leukopenia—Etoposide—germ cell cancer	0.000367	0.00176	CcSEcCtD
Nefazodone—Abdominal pain—Dactinomycin—germ cell cancer	0.000366	0.00176	CcSEcCtD
Nefazodone—Body temperature increased—Dactinomycin—germ cell cancer	0.000366	0.00176	CcSEcCtD
Nefazodone—Anaphylactic shock—Cisplatin—germ cell cancer	0.000366	0.00175	CcSEcCtD
Nefazodone—Oedema—Cisplatin—germ cell cancer	0.000366	0.00175	CcSEcCtD
Nefazodone—Hypersensitivity—Bleomycin—germ cell cancer	0.000366	0.00175	CcSEcCtD
Nefazodone—Infection—Cisplatin—germ cell cancer	0.000363	0.00174	CcSEcCtD
Nefazodone—Pain—Ifosfamide—germ cell cancer	0.000363	0.00174	CcSEcCtD
Nefazodone—Constipation—Ifosfamide—germ cell cancer	0.000363	0.00174	CcSEcCtD
Nefazodone—Loss of consciousness—Etoposide—germ cell cancer	0.000361	0.00173	CcSEcCtD
Nefazodone—Cough—Etoposide—germ cell cancer	0.000358	0.00172	CcSEcCtD
Nefazodone—Thrombocytopenia—Cisplatin—germ cell cancer	0.000358	0.00172	CcSEcCtD
Nefazodone—Tachycardia—Cisplatin—germ cell cancer	0.000357	0.00171	CcSEcCtD
Nefazodone—Asthenia—Bleomycin—germ cell cancer	0.000356	0.00171	CcSEcCtD
Nefazodone—Convulsion—Etoposide—germ cell cancer	0.000356	0.00171	CcSEcCtD
Nefazodone—Hypertension—Etoposide—germ cell cancer	0.000354	0.0017	CcSEcCtD
Nefazodone—Hyperhidrosis—Cisplatin—germ cell cancer	0.000353	0.0017	CcSEcCtD
Nefazodone—Asthma—Methotrexate—germ cell cancer	0.000353	0.00169	CcSEcCtD
Nefazodone—Pruritus—Bleomycin—germ cell cancer	0.000351	0.00168	CcSEcCtD
Nefazodone—ABCB1—telencephalon—germ cell cancer	0.00035	0.00224	CbGeAlD
Nefazodone—Feeling abnormal—Ifosfamide—germ cell cancer	0.000349	0.00168	CcSEcCtD
Nefazodone—Chest pain—Etoposide—germ cell cancer	0.000349	0.00168	CcSEcCtD
Nefazodone—ADRA2A—cerebellum—germ cell cancer	0.000349	0.00224	CbGeAlD
Nefazodone—Nausea—Vinblastine—germ cell cancer	0.000349	0.00167	CcSEcCtD
Nefazodone—Anorexia—Cisplatin—germ cell cancer	0.000348	0.00167	CcSEcCtD
Nefazodone—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000347	0.00166	CcSEcCtD
Nefazodone—Discomfort—Etoposide—germ cell cancer	0.000345	0.00166	CcSEcCtD
Nefazodone—Hypotension—Cisplatin—germ cell cancer	0.000342	0.00164	CcSEcCtD
Nefazodone—Hypersensitivity—Dactinomycin—germ cell cancer	0.000341	0.00164	CcSEcCtD
Nefazodone—Confusional state—Etoposide—germ cell cancer	0.000338	0.00162	CcSEcCtD
Nefazodone—HTR2A—endocrine gland—germ cell cancer	0.000337	0.00216	CbGeAlD
Nefazodone—Urticaria—Ifosfamide—germ cell cancer	0.000337	0.00162	CcSEcCtD
Nefazodone—Abdominal pain—Ifosfamide—germ cell cancer	0.000335	0.00161	CcSEcCtD
Nefazodone—Body temperature increased—Ifosfamide—germ cell cancer	0.000335	0.00161	CcSEcCtD
Nefazodone—Anaphylactic shock—Etoposide—germ cell cancer	0.000335	0.00161	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000333	0.0016	CcSEcCtD
Nefazodone—HTR2A—head—germ cell cancer	0.000333	0.00213	CbGeAlD
Nefazodone—Infection—Etoposide—germ cell cancer	0.000333	0.0016	CcSEcCtD
Nefazodone—Asthenia—Dactinomycin—germ cell cancer	0.000332	0.00159	CcSEcCtD
Nefazodone—ABCB1—decidua—germ cell cancer	0.000332	0.00213	CbGeAlD
Nefazodone—CYP2D6—female gonad—germ cell cancer	0.00033	0.00212	CbGeAlD
Nefazodone—Dysuria—Methotrexate—germ cell cancer	0.00033	0.00158	CcSEcCtD
Nefazodone—Paraesthesia—Cisplatin—germ cell cancer	0.000328	0.00158	CcSEcCtD
Nefazodone—Thrombocytopenia—Etoposide—germ cell cancer	0.000328	0.00157	CcSEcCtD
Nefazodone—Tachycardia—Etoposide—germ cell cancer	0.000327	0.00157	CcSEcCtD
Nefazodone—Dyspnoea—Cisplatin—germ cell cancer	0.000326	0.00156	CcSEcCtD
Nefazodone—Erectile dysfunction—Methotrexate—germ cell cancer	0.000325	0.00156	CcSEcCtD
Nefazodone—Hyperhidrosis—Etoposide—germ cell cancer	0.000324	0.00155	CcSEcCtD
Nefazodone—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000322	0.00155	CcSEcCtD
Nefazodone—HTR2A—testis—germ cell cancer	0.000321	0.00206	CbGeAlD
Nefazodone—Anorexia—Etoposide—germ cell cancer	0.000319	0.00153	CcSEcCtD
Nefazodone—Decreased appetite—Cisplatin—germ cell cancer	0.000318	0.00153	CcSEcCtD
Nefazodone—Diarrhoea—Dactinomycin—germ cell cancer	0.000317	0.00152	CcSEcCtD
Nefazodone—Pneumonia—Methotrexate—germ cell cancer	0.000316	0.00152	CcSEcCtD
Nefazodone—Vomiting—Bleomycin—germ cell cancer	0.000315	0.00151	CcSEcCtD
Nefazodone—Hypotension—Etoposide—germ cell cancer	0.000313	0.0015	CcSEcCtD
Nefazodone—Rash—Bleomycin—germ cell cancer	0.000313	0.0015	CcSEcCtD
Nefazodone—Pain—Cisplatin—germ cell cancer	0.000313	0.0015	CcSEcCtD
Nefazodone—Dermatitis—Bleomycin—germ cell cancer	0.000313	0.0015	CcSEcCtD
Nefazodone—Hypersensitivity—Ifosfamide—germ cell cancer	0.000312	0.0015	CcSEcCtD
Nefazodone—CYP3A4—endocrine gland—germ cell cancer	0.000312	0.002	CbGeAlD
Nefazodone—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000312	0.0015	CcSEcCtD
Nefazodone—CYP2D6—endocrine gland—germ cell cancer	0.000307	0.00197	CbGeAlD
Nefazodone—Stomatitis—Methotrexate—germ cell cancer	0.000307	0.00147	CcSEcCtD
Nefazodone—Conjunctivitis—Methotrexate—germ cell cancer	0.000306	0.00147	CcSEcCtD
Nefazodone—Asthenia—Ifosfamide—germ cell cancer	0.000304	0.00146	CcSEcCtD
Nefazodone—CYP2D6—head—germ cell cancer	0.000303	0.00194	CbGeAlD
Nefazodone—Sweating—Methotrexate—germ cell cancer	0.000302	0.00145	CcSEcCtD
Nefazodone—Feeling abnormal—Cisplatin—germ cell cancer	0.000301	0.00145	CcSEcCtD
Nefazodone—Paraesthesia—Etoposide—germ cell cancer	0.000301	0.00144	CcSEcCtD
Nefazodone—Pruritus—Ifosfamide—germ cell cancer	0.0003	0.00144	CcSEcCtD
Nefazodone—Haematuria—Methotrexate—germ cell cancer	0.0003	0.00144	CcSEcCtD
Nefazodone—Dyspnoea—Etoposide—germ cell cancer	0.000299	0.00143	CcSEcCtD
Nefazodone—Somnolence—Etoposide—germ cell cancer	0.000298	0.00143	CcSEcCtD
Nefazodone—HTR2A—cerebellum—germ cell cancer	0.000297	0.0019	CbGeAlD
Nefazodone—Epistaxis—Methotrexate—germ cell cancer	0.000297	0.00142	CcSEcCtD
Nefazodone—Nausea—Bleomycin—germ cell cancer	0.000295	0.00141	CcSEcCtD
Nefazodone—Vomiting—Dactinomycin—germ cell cancer	0.000294	0.00141	CcSEcCtD
Nefazodone—CYP2D6—testis—germ cell cancer	0.000293	0.00188	CbGeAlD
Nefazodone—ABCB1—gonad—germ cell cancer	0.000292	0.00187	CbGeAlD
Nefazodone—Rash—Dactinomycin—germ cell cancer	0.000292	0.0014	CcSEcCtD
Nefazodone—Decreased appetite—Etoposide—germ cell cancer	0.000291	0.0014	CcSEcCtD
Nefazodone—ABCB1—uterus—germ cell cancer	0.00029	0.00186	CbGeAlD
Nefazodone—Diarrhoea—Ifosfamide—germ cell cancer	0.00029	0.00139	CcSEcCtD
Nefazodone—Body temperature increased—Cisplatin—germ cell cancer	0.000289	0.00139	CcSEcCtD
Nefazodone—Constipation—Etoposide—germ cell cancer	0.000286	0.00137	CcSEcCtD
Nefazodone—Pain—Etoposide—germ cell cancer	0.000286	0.00137	CcSEcCtD
Nefazodone—ABCB1—pituitary gland—germ cell cancer	0.000285	0.00183	CbGeAlD
Nefazodone—Haemoglobin—Methotrexate—germ cell cancer	0.000284	0.00136	CcSEcCtD
Nefazodone—ADRA2A—brain—germ cell cancer	0.000284	0.00182	CbGeAlD
Nefazodone—Haemorrhage—Methotrexate—germ cell cancer	0.000282	0.00136	CcSEcCtD
Nefazodone—Hepatitis—Methotrexate—germ cell cancer	0.000282	0.00136	CcSEcCtD
Nefazodone—Dizziness—Ifosfamide—germ cell cancer	0.00028	0.00135	CcSEcCtD
Nefazodone—Pharyngitis—Methotrexate—germ cell cancer	0.00028	0.00135	CcSEcCtD
Nefazodone—Feeling abnormal—Etoposide—germ cell cancer	0.000276	0.00132	CcSEcCtD
Nefazodone—ABCB1—medulla oblongata—germ cell cancer	0.000275	0.00176	CbGeAlD
Nefazodone—Nausea—Dactinomycin—germ cell cancer	0.000275	0.00132	CcSEcCtD
Nefazodone—ADRA2A—lymph node—germ cell cancer	0.000274	0.00176	CbGeAlD
Nefazodone—Gastrointestinal pain—Etoposide—germ cell cancer	0.000274	0.00131	CcSEcCtD
Nefazodone—Visual impairment—Methotrexate—germ cell cancer	0.000272	0.00131	CcSEcCtD
Nefazodone—CYP2D6—cerebellum—germ cell cancer	0.00027	0.00173	CbGeAlD
Nefazodone—Vomiting—Ifosfamide—germ cell cancer	0.00027	0.00129	CcSEcCtD
Nefazodone—Hypersensitivity—Cisplatin—germ cell cancer	0.000269	0.00129	CcSEcCtD
Nefazodone—Rash—Ifosfamide—germ cell cancer	0.000267	0.00128	CcSEcCtD
Nefazodone—Dermatitis—Ifosfamide—germ cell cancer	0.000267	0.00128	CcSEcCtD
Nefazodone—Erythema multiforme—Methotrexate—germ cell cancer	0.000267	0.00128	CcSEcCtD
Nefazodone—Urticaria—Etoposide—germ cell cancer	0.000266	0.00128	CcSEcCtD
Nefazodone—Abdominal pain—Etoposide—germ cell cancer	0.000265	0.00127	CcSEcCtD
Nefazodone—Body temperature increased—Etoposide—germ cell cancer	0.000265	0.00127	CcSEcCtD
Nefazodone—Tinnitus—Methotrexate—germ cell cancer	0.000263	0.00126	CcSEcCtD
Nefazodone—Asthenia—Cisplatin—germ cell cancer	0.000262	0.00126	CcSEcCtD
Nefazodone—ABCB1—adrenal gland—germ cell cancer	0.000255	0.00163	CbGeAlD
Nefazodone—Chills—Methotrexate—germ cell cancer	0.000253	0.00122	CcSEcCtD
Nefazodone—Nausea—Ifosfamide—germ cell cancer	0.000252	0.00121	CcSEcCtD
Nefazodone—ABCB1—midbrain—germ cell cancer	0.000251	0.00161	CbGeAlD
Nefazodone—Diarrhoea—Cisplatin—germ cell cancer	0.00025	0.0012	CcSEcCtD
Nefazodone—Alopecia—Methotrexate—germ cell cancer	0.000249	0.0012	CcSEcCtD
Nefazodone—Hypersensitivity—Etoposide—germ cell cancer	0.000247	0.00118	CcSEcCtD
Nefazodone—ABCB1—bone marrow—germ cell cancer	0.000246	0.00158	CbGeAlD
Nefazodone—ABCB1—spinal cord—germ cell cancer	0.000245	0.00157	CbGeAlD
Nefazodone—HTR2A—brain—germ cell cancer	0.000241	0.00155	CbGeAlD
Nefazodone—Dysgeusia—Methotrexate—germ cell cancer	0.000241	0.00116	CcSEcCtD
Nefazodone—Asthenia—Etoposide—germ cell cancer	0.00024	0.00115	CcSEcCtD
Nefazodone—Back pain—Methotrexate—germ cell cancer	0.000238	0.00114	CcSEcCtD
Nefazodone—ABCB1—female gonad—germ cell cancer	0.000238	0.00152	CbGeAlD
Nefazodone—Pruritus—Etoposide—germ cell cancer	0.000237	0.00114	CcSEcCtD
Nefazodone—Vomiting—Cisplatin—germ cell cancer	0.000232	0.00112	CcSEcCtD
Nefazodone—Vision blurred—Methotrexate—germ cell cancer	0.000232	0.00111	CcSEcCtD
Nefazodone—Rash—Cisplatin—germ cell cancer	0.00023	0.00111	CcSEcCtD
Nefazodone—Dermatitis—Cisplatin—germ cell cancer	0.00023	0.00111	CcSEcCtD
Nefazodone—Diarrhoea—Etoposide—germ cell cancer	0.000229	0.0011	CcSEcCtD
Nefazodone—Ill-defined disorder—Methotrexate—germ cell cancer	0.000228	0.00109	CcSEcCtD
Nefazodone—Anaemia—Methotrexate—germ cell cancer	0.000227	0.00109	CcSEcCtD
Nefazodone—Malaise—Methotrexate—germ cell cancer	0.000222	0.00106	CcSEcCtD
Nefazodone—Dizziness—Etoposide—germ cell cancer	0.000221	0.00106	CcSEcCtD
Nefazodone—ABCB1—endocrine gland—germ cell cancer	0.000221	0.00142	CbGeAlD
Nefazodone—Vertigo—Methotrexate—germ cell cancer	0.000221	0.00106	CcSEcCtD
Nefazodone—Leukopenia—Methotrexate—germ cell cancer	0.00022	0.00106	CcSEcCtD
Nefazodone—CYP2D6—brain—germ cell cancer	0.00022	0.00141	CbGeAlD
Nefazodone—ABCB1—head—germ cell cancer	0.000218	0.0014	CbGeAlD
Nefazodone—Nausea—Cisplatin—germ cell cancer	0.000217	0.00104	CcSEcCtD
Nefazodone—Cough—Methotrexate—germ cell cancer	0.000214	0.00103	CcSEcCtD
Nefazodone—Convulsion—Methotrexate—germ cell cancer	0.000213	0.00102	CcSEcCtD
Nefazodone—Vomiting—Etoposide—germ cell cancer	0.000213	0.00102	CcSEcCtD
Nefazodone—Rash—Etoposide—germ cell cancer	0.000211	0.00101	CcSEcCtD
Nefazodone—Dermatitis—Etoposide—germ cell cancer	0.000211	0.00101	CcSEcCtD
Nefazodone—ABCB1—testis—germ cell cancer	0.000211	0.00135	CbGeAlD
Nefazodone—Headache—Etoposide—germ cell cancer	0.00021	0.00101	CcSEcCtD
Nefazodone—Myalgia—Methotrexate—germ cell cancer	0.000209	0.001	CcSEcCtD
Nefazodone—Chest pain—Methotrexate—germ cell cancer	0.000209	0.001	CcSEcCtD
Nefazodone—Arthralgia—Methotrexate—germ cell cancer	0.000209	0.001	CcSEcCtD
Nefazodone—Discomfort—Methotrexate—germ cell cancer	0.000207	0.000992	CcSEcCtD
Nefazodone—Confusional state—Methotrexate—germ cell cancer	0.000202	0.000971	CcSEcCtD
Nefazodone—Anaphylactic shock—Methotrexate—germ cell cancer	0.000201	0.000963	CcSEcCtD
Nefazodone—Infection—Methotrexate—germ cell cancer	0.000199	0.000957	CcSEcCtD
Nefazodone—Nausea—Etoposide—germ cell cancer	0.000199	0.000955	CcSEcCtD
Nefazodone—Thrombocytopenia—Methotrexate—germ cell cancer	0.000196	0.000943	CcSEcCtD
Nefazodone—ABCB1—cerebellum—germ cell cancer	0.000195	0.00125	CbGeAlD
Nefazodone—Hyperhidrosis—Methotrexate—germ cell cancer	0.000194	0.000931	CcSEcCtD
Nefazodone—Anorexia—Methotrexate—germ cell cancer	0.000191	0.000918	CcSEcCtD
Nefazodone—Hypotension—Methotrexate—germ cell cancer	0.000187	0.0009	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000183	0.000877	CcSEcCtD
Nefazodone—Insomnia—Methotrexate—germ cell cancer	0.000181	0.000871	CcSEcCtD
Nefazodone—Paraesthesia—Methotrexate—germ cell cancer	0.00018	0.000865	CcSEcCtD
Nefazodone—Dyspnoea—Methotrexate—germ cell cancer	0.000179	0.000858	CcSEcCtD
Nefazodone—Somnolence—Methotrexate—germ cell cancer	0.000178	0.000856	CcSEcCtD
Nefazodone—Dyspepsia—Methotrexate—germ cell cancer	0.000177	0.000848	CcSEcCtD
Nefazodone—Decreased appetite—Methotrexate—germ cell cancer	0.000174	0.000837	CcSEcCtD
Nefazodone—Pain—Methotrexate—germ cell cancer	0.000172	0.000823	CcSEcCtD
Nefazodone—Feeling abnormal—Methotrexate—germ cell cancer	0.000165	0.000793	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000164	0.000787	CcSEcCtD
Nefazodone—Urticaria—Methotrexate—germ cell cancer	0.000159	0.000765	CcSEcCtD
Nefazodone—Body temperature increased—Methotrexate—germ cell cancer	0.000159	0.000761	CcSEcCtD
Nefazodone—Abdominal pain—Methotrexate—germ cell cancer	0.000159	0.000761	CcSEcCtD
Nefazodone—ABCB1—brain—germ cell cancer	0.000158	0.00101	CbGeAlD
Nefazodone—ABCB1—lymph node—germ cell cancer	0.000153	0.000979	CbGeAlD
Nefazodone—Hypersensitivity—Methotrexate—germ cell cancer	0.000148	0.000709	CcSEcCtD
Nefazodone—Asthenia—Methotrexate—germ cell cancer	0.000144	0.000691	CcSEcCtD
Nefazodone—Pruritus—Methotrexate—germ cell cancer	0.000142	0.000681	CcSEcCtD
Nefazodone—Diarrhoea—Methotrexate—germ cell cancer	0.000137	0.000659	CcSEcCtD
Nefazodone—Dizziness—Methotrexate—germ cell cancer	0.000133	0.000637	CcSEcCtD
Nefazodone—Vomiting—Methotrexate—germ cell cancer	0.000128	0.000612	CcSEcCtD
Nefazodone—Rash—Methotrexate—germ cell cancer	0.000126	0.000607	CcSEcCtD
Nefazodone—Dermatitis—Methotrexate—germ cell cancer	0.000126	0.000607	CcSEcCtD
Nefazodone—Headache—Methotrexate—germ cell cancer	0.000126	0.000603	CcSEcCtD
Nefazodone—Nausea—Methotrexate—germ cell cancer	0.000119	0.000572	CcSEcCtD
